Healthcare systems are under pressure, faced with workforce shortages, an ageing population and increases in non-communicable diseases (NCDs). Budgetary limits and climate disasters further add to the burden, leaving systems overstretched, vulnerable and ill-equipped to respond to future needs. These challenges call for vision, cooperation and above all: action.

Against this backdrop, the Partnership for Health System Sustainability and Resilience (PHSSR) aims to build more sustainable and resilient health systems. PHSSR is a non-profit, global collaboration between London School of Economics, the WHO Foundation, the World Economic Forum, AstraZeneca, KPMG, Philips, the Center for Asia-Pacific Resilience and Innovation (CAPRI).

Building on the Belgian PHSSR-report published in 2023, AstraZeneca BeLux worked alongside Prof. Annemans to establish a Think Tank on the Future of Healthcare. This group of diverse experts -under the leadership and authorship of Prof. Annemans – was tasked with developing a framework for future-proofing the Belgian healthcare system. The resulting paper ‘Towards a future-proof health system in Belgium’ outlines 10 key principles as well as guidance for their practical implementation.

During an event in the Federal Parliament on the 13th of June 2025, the Think Tank gathered alongside policymakers, healthcare professionals, academics and patient advocates to share insights on the future of our healthcare system. This milestone merely marks the beginning of our journey towards future-proofing the Belgian healthcare system. We are keen to bring additional stakeholders on board to build tomorrow's healthcare together.

If you are interested in joining the Think Tank and/or this initiative, please contact Laura Capitaine: [email protected] - Corporate Affairs Lead

Cancer remains a leading cause of death globally. Advanced diagnostics are revolutionizing cancer care by enabling faster, more accurate and personalized treatment decisions.

Our latest whitepaper, developed in collaboration with patient advocates, medical experts, health authorities, and insurance experts, dives deep into the barriers and breakthroughs of advanced diagnostics in on.

Discover how timely and equitable access, patient-centered policies, and holistic reimbursement models can revolutionize cancer care, improve patient outcomes, and enhance their quality of life.

If you are shaping cancer care – or care about it – this is essential reading.

The Ruysbroeckveld Nature Park in Sint-Pieters-Leeuw, developed in collaboration with AstraZeneca, has entered a new phase of expansion. In autumn 2024, AstraZeneca BeLux employees planted 2,600 trees, bringing the park closer to its goal of becoming a 5-hectare green oasis near Brussels.

This initiative, led by the local government of Sint-Pieters-Leeuw and supported by AstraZeneca, Forest Fwd and the Flemish government, aims to enhance biodiversity and improve the quality of life for local residents. With new green spaces, walking paths and recreational areas, the park contributes to a healthier environment.

AstraZeneca’s commitment to sustainability extends beyond medicine, supporting projects like this to improve air quality and public health.

At AstraZeneca BeLux, inclusivity and employee well-being are at the heart of our workplace. In 2024, we introduced extended birth leave for fathers and co-parents, reinforcing our commitment to equitable parental support.

This initiative adds two extra months to the 20 legally mandated days, allowing fathers and co-parents to fully embrace this life-changing moment. By promoting shared caregiving responsibilities, AstraZeneca aims to foster a more balanced and inclusive work environment.

As a leader in the pharmaceutical industry, we continue to drive meaningful change, ensuring all employees can thrive both personally and professionally.

We are thrilled to announce that AstraZeneca BeLux has been recognized as a Great Place to Work for the second time, achieving an outstanding 94% employee satisfaction score!

This prestigious title, awarded by the Great Place to Work Institute in collaboration with Vlerick Business School, reflects the pride and dedication of our 240+ employees. An impressive 97% feel proud of their contributions at AstraZeneca BeLux.

We are committed to fostering a culture of empowerment, innovation, and inclusion, ensuring our people thrive while making a meaningful impact on patients, society, and the planet.

A huge thank you to everyone who makes AstraZeneca BeLux a great place to work—together, we are shaping a brighter future!